Fibrobiologics Inc (FBLG)

Dec 30, 2024, 4:30 PM EST - 18 days ago

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Dec 30, 2024, 2:12 PM EST - 18 days ago

D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing

Dec 23, 2024, 7:55 AM EST - 25 days ago

FibroBiologics Announces $25 Million Financing

Nov 19, 2024, 9:15 AM EST - 2 months ago

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly

Nov 14, 2024, 9:15 AM EST - 2 months ago

FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics

Nov 12, 2024, 4:20 PM EST - 2 months ago

FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Oct 29, 2024, 9:15 AM EDT - 2 months ago

FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology

Oct 28, 2024, 9:31 AM EDT - 2 months ago

FibroBiologics to Present at the 2024 ThinkEquity Conference and BIO-Europe 2024

Oct 18, 2024, 8:30 AM EDT - 3 months ago

FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases

Oct 16, 2024, 9:15 AM EDT - 3 months ago

FibroBiologics Issued Patent for Fibroblast Delivery of Tumor Inhibitory Agents by the European Patent Office

Oct 11, 2024, 9:31 AM EDT - 3 months ago

FibroBiologics to Participate in a Fireside Chat at 2024 Maxim Healthcare Virtual Summit

Sep 30, 2024, 9:31 AM EDT - 3 months ago

FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa

Sep 19, 2024, 9:31 AM EDT - 4 months ago

FibroBiologics Engages Southern Star Research as CRO in Australia

Sep 12, 2024, 9:31 AM EDT - 4 months ago

FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology

Sep 6, 2024, 9:31 AM EDT - 4 months ago

FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Aug 20, 2024, 9:31 AM EDT - 5 months ago

FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based Technology

Aug 7, 2024, 6:52 PM EDT - 5 months ago

FibroBiologics Files 2024 Second Quarter Report

Jul 15, 2024, 9:31 AM EDT - 6 months ago

FibroBiologics to Present at JonesTrading Healthcare Summit 2024

Jun 25, 2024, 9:31 AM EDT - 7 months ago

FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology

Jun 13, 2024, 9:31 AM EDT - 7 months ago

FibroBiologics Set to Join Russell 2000® Index

Jun 6, 2024, 9:31 AM EDT - 8 months ago

FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024

May 15, 2024, 4:30 PM EDT - 8 months ago

FibroBiologics Announces 2024 Annual Meeting of Stockholders

May 14, 2024, 5:24 PM EDT - 8 months ago

FibroBiologics Files 2024 First Quarter Report

May 7, 2024, 9:31 AM EDT - 9 months ago

FibroBiologics to Present at the BIO International Convention 2024

Apr 11, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office

Apr 4, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

Mar 28, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus

Mar 19, 2024, 9:31 AM EDT - 10 months ago

FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment

Mar 13, 2024, 9:31 AM EDT - 11 months ago

FibroBiologics to Present at Advanced Wound Care Summit USA

Mar 6, 2024, 9:31 AM EST - 11 months ago

FibroBiologics Appoints Ruben A. Garcia as General Counsel

Feb 29, 2024, 5:44 PM EST - 11 months ago

FibroBiologics Files 2023 Form 10-K Annual Report

Feb 20, 2024, 9:31 AM EST - 11 months ago

FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum

Feb 13, 2024, 9:31 AM EST - 1 year ago

FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases

Feb 8, 2024, 9:31 AM EST - 1 year ago

FibroBiologics Announces Three United States Patents for Fibroblast Technology

Feb 6, 2024, 9:31 AM EST - 1 year ago

FibroBiologics Announces Three Japanese Patents on Fibroblast Technology

Feb 4, 2024, 6:16 AM EST - 1 year ago

U.S. IPO Weekly Recap: Amer Sports' Billion-Dollar U.S. IPO Leads A Week Of Large Listings

AS AHR AMDI ANRO FLUT GUTS KYTX

Jan 31, 2024, 10:00 AM EST - 1 year ago

FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG

Nov 12, 2023, 11:15 AM EST - 1 year ago

U.S. IPO Weekly Recap: Reinsurance And CAR T Therapies Lead A 3 IPO Week

AMDI CRGX DDC GVH HG HWEP SHIM

Nov 8, 2023, 10:27 AM EST - 1 year ago

Biopharma Firm FibroBiologics Seeks U.S. Direct Listing